Dae-Sung Kim

Directeur/Membre du Conseil chez Great Orient Chemical Pte Ltd.

60 ans

Process Industries

Health Technology

Consumer Services

Postes actifs de Dae-Sung Kim

Sociétés	Poste	Début	Fin
ID Biochem, Inc. ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million.	Comptroller/Controller/Auditor	-	-
Great Orient Chemical Pte Ltd.	Directeur/Membre du Conseil	-	-

Sociétés	Poste	Début	Fin
ISU ABXIS CO., LTD.	Directeur/Membre du Conseil	12/11/2010	-
	Directeur Général	30/06/2014	24/03/2017
	Corporate Officer/Principal	11/08/2011	30/06/2014
ISU PETASYS CO., LTD.	Directeur/Membre du Conseil	-	-
ISU PETASYS CO., LTD.	Corporate Officer/Principal	-	-
ISU CHEMICAL CO., LTD	Directeur/Membre du Conseil	06/09/2010	-
ISU CHEMICAL CO., LTD	Directeur Financier/CFO	06/09/2010	-

Seoul National University

Undergraduate Degree

Internationale

Corée du Sud	6
Singapour	2

Opérationnelle

Director/Board Member	4
Corporate Officer/Principal	2
Director of Finance/CFO	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
ID Biochem, Inc. ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million.	Process Industries
Great Orient Chemical Pte Ltd.